Pearson will be responsible for the day-to-day operations at the fluid handling component manufacturing plant. He was previously business operations manager at Weetabix (Northamptonshire, UK) and site manager at Nampak Plastics Europe (Buckinghamshire, UK).
Diba, part of the multinational Halma technology group, provides custom engineered fluid handling components and design services. The company is headquartered in Danbury, Connecticut, US with global locations in the UK, China, and Japan.
Diba names new general manager
Mick Pearson takes responsibility for the Cambridge, UK fluid handling component plant
You may also like
Manufacturing
![Precise dosing valve developed for demanding laboratory and analytical systems]()
Precise dosing valve developed for demanding laboratory and analytical systems
Flow control specialist Bürkert has announced the release of a new dosing valve with media separation that offers minimal internal volume, fast switching times and high repeatability to ensure stable processes and reproducible results
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Manufacturing
![How intelligent checkweighers offer improved productivity in pharmaceutical manufacturing]()
How intelligent checkweighers offer improved productivity in pharmaceutical manufacturing
Precise weighing, automated reporting and tailored handling help pharmaceutical producers reduce waste, streamline compliance processes and maintain reliable output across demanding production lines
Manufacturing
![Shilpa CDMO invests $50m to expand peptide manufacturing capacity in India]()
Shilpa CDMO invests $50m to expand peptide manufacturing capacity in India
The CDMO is investing $50m in additional solid-phase peptide synthesis capacity and a new commercial manufacturing line at its Raichur campus, expanding its capabilities to meet demand for GLP-1s and increasingly complex peptide therapeutics across oncology and rare diseases
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
